Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

Management

The management team at Celator includes industry leaders who have played key roles in the development and commercialization of many pharmaceutical products.

Scott Jackson, R.Ph., M.B.A., Chief Executive Officer   |  bio

Lawrence Mayer, Ph.D., Founder, President & Head of Research  |  bio

Arthur C. Louie, M.D., Chief Medical Officer  |  bio

Donna Cabral-Lilly, Ph.D., Head of Pharmaceutical Development  |  bio

David Wood, M.B.A., C.M.A., Head of Finance and Corporate Development  |  bio

 

 

 


Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

 

 

 

 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.